Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Simon Fraser University

$12,103.00

Post-transcriptional regulation of hematopoietic stem cell function and cell fate determination during hematopoiesis

EF 2021-22

Résumé
Cell fate determination is a fundamental area in stem cell biology and critical to understanding the development and maintenance of functional organs. Hematopoiesis, the process of blood formation, is driven by hematopoietic stem cells (HSCs). HSCs are a small population of cells, which possess unique self-renewal ability to reconstitute all terminally differentiated cells in the system throughout a lifetime. During hematopoiesis, each step of cell fate determination is orchestrated and regulated by activation of a specific gene expression program, resulting in transcription of mRNAs and subsequently generation of functional proteins. However, little is known about how processes of protein synthesis i.e. post-transcriptional control impacts stem cell self-renewal and differentiation. After a native mRNA is made, it undergoes addition of a polyadenine (poly-A) tail, which helps protect mRNA from degradation and supports translation of mRNA to protein. PolyA deadenylation mediates the shortening of the poly(A) tail and starts the RNA decay process of mRNAs. The CCR4-NOT (CNOT) complex is one of two multi-subunit polyA deadenylation complexes. Recently, I discovered that RNA methylation m6A "writer" METTL3 is an important regulator of hematopoietic stem cells (HSCs) and translation. CNOT complex was recruited to m6A transcripts to mediate the mRNA degradation. Among all subunits of the CNOT complex, CNOT3 exhibits the highest expression in HSCs and is downregulated in progenitors and differentiated cells. Given central roles of the CNOT complex and the regulatory link between translation and mRNA decay, we aim to investigate a role for the CNOT complex, in particular CNOT3 in regulation of HSCs and hematopoiesis to uncover novel mechanisms underlying cell fate decision. The overarching goal of my research program is to determine post-transcriptional and translational mechanisms of gene expression regulation in control of HSC function and cell fate determination during normal hematopoiesis. Over the next 5 years, we will uncover the role of CNOT3 and the CCR4-NOT mediated deadenylation in HSCs and hematopoiesis. We hypothesize that control of mRNA decay and translation mediated by the CNOT complex is critical for cell fate determination in hematopoietic systems. Specifically, we propose 3 aims: AIM 1. Define the role of CNOT3 in normal hematopoiesis, AIM 2. Determine CNOT3 function in the regulation of HSC cell fate (i.e. HSC quiescence, cell cycle and control of asymmetric and symmetric division) AIM 3. Define the molecular mechanism for CNOT3 function in hematopoietic stem cells. These studies will identify novel mediators of blood cell maintenance and regeneration, as well as novel molecular mechanisms of mRNA degradation and translation cross-talk. The results will advance our knowledge in stem cell biology while providing insights to the elusive post-transcriptional research field.
Programme
Discovery Grants Program - Individual
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2019-07018
Name nom
Vu, Ly
Department département
Pharmaceutical Sciences, Faculty of - Pharmaceutical Sciences, Faculty of
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2019
Award amount
12103
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5105
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell differentiation
Research subject fr
Différenciation cellulaire
Installment
inst:3
Partie
1
Nb partie
5
Application title
Post-transcriptional regulation of hematopoietic stem cell function and cell fate determination during hematopoiesis
Keyword
NSERC
Application summary
Cell fate determination is a fundamental area in stem cell biology and critical to understanding the development and maintenance of functional organs. Hematopoiesis, the process of blood formation, is driven by hematopoietic stem cells (HSCs). HSCs are a small population of cells, which possess unique self-renewal ability to reconstitute all terminally differentiated cells in the system throughout a lifetime. During hematopoiesis, each step of cell fate determination is orchestrated and regulated by activation of a specific gene expression program, resulting in transcription of mRNAs and subsequently generation of functional proteins. However, little is known about how processes of protein synthesis i.e. post-transcriptional control impacts stem cell self-renewal and differentiation. After a native mRNA is made, it undergoes addition of a polyadenine (poly-A) tail, which helps protect mRNA from degradation and supports translation of mRNA to protein. PolyA deadenylation mediates the shortening of the poly(A) tail and starts the RNA decay process of mRNAs. The CCR4-NOT (CNOT) complex is one of two multi-subunit polyA deadenylation complexes. Recently, I discovered that RNA methylation m6A "writer" METTL3 is an important regulator of hematopoietic stem cells (HSCs) and translation. CNOT complex was recruited to m6A transcripts to mediate the mRNA degradation. Among all subunits of the CNOT complex, CNOT3 exhibits the highest expression in HSCs and is downregulated in progenitors and differentiated cells. Given central roles of the CNOT complex and the regulatory link between translation and mRNA decay, we aim to investigate a role for the CNOT complex, in particular CNOT3 in regulation of HSCs and hematopoiesis to uncover novel mechanisms underlying cell fate decision. The overarching goal of my research program is to determine post-transcriptional and translational mechanisms of gene expression regulation in control of HSC function and cell fate determination during normal hematopoiesis. Over the next 5 years, we will uncover the role of CNOT3 and the CCR4-NOT mediated deadenylation in HSCs and hematopoiesis. We hypothesize that control of mRNA decay and translation mediated by the CNOT complex is critical for cell fate determination in hematopoietic systems. Specifically, we propose 3 aims: AIM 1. Define the role of CNOT3 in normal hematopoiesis, AIM 2. Determine CNOT3 function in the regulation of HSC cell fate (i.e. HSC quiescence, cell cycle and control of asymmetric and symmetric division) AIM 3. Define the molecular mechanism for CNOT3 function in hematopoietic stem cells. These studies will identify novel mediators of blood cell maintenance and regeneration, as well as novel molecular mechanisms of mRNA degradation and translation cross-talk. The results will advance our knowledge in stem cell biology while providing insights to the elusive post-transcriptional research field.